Titan Pharmaceuticals announces 1-for-30 reverse stock split

Nov. 30, 2020 1:08 PM ETTitan Pharmaceuticals, Inc. (TTNP)TTNPBy: Meghavi Singh, SA News Editor5 Comments
  • Titan Pharmaceuticals (TTNP -5.6%) after its Board of Directors approved a 1-for-30 reverse stock split of the Company’s common stock, which will be effective at 5:00 p.m.ET today.
  • The Company’s stockholders approved the reverse stock split at the Special Meeting of Stockholders on November 30. The Company’s shares will begin trading on a split-adjusted basis commencing upon market open on December 1.
  • Immediately after the reverse split becomes effective, there will be ~6.6M common shares issued and outstanding.
  • The common shares will trade under a new CUSIP number, 888314606, effective December 1, and continue to trade under the symbol "TTNP."

Recommended For You

Comments (5)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.